Monday, August 28, 2017

4th Annual Rare Disease Market Access and Commercialization Summit

4th Annual Rare Disease Market Access and Commercialization Summit
October 23-24, 2017 | Boston, MA
www.worldcongress.com/raredisease

Join your peers at the 4th Annual Rare Disease Market Access and Commercialization Summit for a deep examination of the challenges, innovations and techniques for achieving commercial success and navigating the payer landscape.

How will you benefit?
  • Establish best practices when approaching value-based contracting, specifically for rare therapies
  • Analyze recent policy and industry changes, paired with the rising status of the patient voice as a stakeholder, and their joint effect on the drug development lifecycle
  • Payer guidance (Blue Cross Blue Shield of Minnesota) on the reimbursement conundrum
  • Review Amgen and Harvard Pilgrim's outcomes-based contract for Repatha
  • Explore Shire andPatientsLikeMe's collaboration expanding traditional clinical trial monitoring towards the use of real world data and consolidation in a single digital platform
  • Gain insight from manufacturers' and Walgreens on how to develop a specialty pharma channel strategy for a rare disease product launch
  • Hear specific examples of successful marketing strategies for recent rare disease product launches that satisfied stakeholders' needs
Register today – Use discount code DC200 and save $200!

Visit www.worldcongress.com/raredisease for more information.


The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees.

No comments:

Post a Comment

Related Posts Plugin for WordPress, Blogger...